Involvement of Estrogen Receptor-α in the Activation of Nrf2-Antioxidative Signaling Pathways by Silibinin in Pancreatic β-Cells

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2019 Oct 26

PMID 31649209

Citations 11

Authors

Chun Chu

Xiang Gao

Xiang Li

Xiaoying Zhang

Ruixin Ma

Ying Jia

Dahong Li

Dongkai Wang

Fanxing Xu

Affiliations

Soon will be listed here.

Abstract

Silibinin exhibits antidiabetic potential by preserving the mass and function of pancreatic β-cells through up-regulation of estrogen receptor-α (ERα) expression. However, the underlying protective mechanism of silibinin in pancreatic β-cells is still unclear. In the current study, we sought to determine whether ERα acts as the target of silibinin for the modulation of antioxidative response in pancreatic β-cells under high glucose and high fat conditions. Our study revealed that a 4-week oral administration of silibinin (100 mg/kg/day) decreased fasting blood glucose with a concurrent increase in levels of serum insulin in high-fat diet/streptozotocin- induced type 2 diabetic rats. Moreover, expression of ERα, NF-E2-related factor 2 (Nrf2), and heme oxygenase-1 (HO-1) in pancreatic β-cells in pancreatic islets was increased by silibinin treatment. Accordingly, silibinin (10 µM) elevated viability, insulin biosynthesis, and insulin secretion of high glucose/palmitate-treated INS-1 cells accompanied by increased expression of ERα, Nrf2, and HO-1 as well as decreased reactive oxygen species production . Treatment using an ERα antagonist (MPP) in INS-1 cells or silencing ERα expression in INS-1 and NIT-1 cells with siRNA abolished the protective effects of silibinin. Our study suggests that silibinin activates the Nrf2-antioxidative pathways in pancreatic β-cells through regulation of ERα expression.

Citing Articles

Antioxidant 1,2,3,4,6-Penta--galloyl-β-D-glucose Alleviating Apoptosis and Promoting Bone Formation Is Associated with Estrogen Receptors.

Hua Y, Wang H, Chen T, Zhou Y, Chen Z, Zhao X Molecules. 2024; 29(21).

PMID: 39519751 PMC: 11547736. DOI: 10.3390/molecules29215110.

Effect of the Mediterranean Diet (MeDi) on the Progression of Retinal Disease: A Narrative Review.

Sbai O, Torrisi F, Fabrizio F, Rabbeni G, Perrone L Nutrients. 2024; 16(18).

PMID: 39339769 PMC: 11434766. DOI: 10.3390/nu16183169.

Silibinin as a promising treatment for diabetes: Insights into behavioral and metabolic changes in an animal model.

Dagli Gul A, Ozcan G, Arihan O Food Sci Nutr. 2024; 12(5):3336-3345.

PMID: 38726421 PMC: 11077243. DOI: 10.1002/fsn3.3999.

Bio-Actives from Natural Products with Potential Cardioprotective Properties: Isolation, Identification, and Pharmacological Actions of Apigenin, Quercetin, and Silibinin.

Tomou E, Papakyriakopoulou P, Skaltsa H, Valsami G, Kadoglou N Molecules. 2023; 28(5).

PMID: 36903630 PMC: 10005323. DOI: 10.3390/molecules28052387.

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones.

Liu H, Cao M, Jin Y, Jia B, Wang L, Dong M Front Endocrinol (Lausanne). 2023; 14:1031895.

PMID: 36864834 PMC: 9971497. DOI: 10.3389/fendo.2023.1031895.

References

Hidalgo-Lanussa O, Avila-Rodriguez M, Baez-Jurado E, Zamudio J, Echeverria V, Garcia-Segura L . Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta. Mol Neurobiol. 2017; 55(7):5462-5477. DOI: 10.1007/s12035-017-0777-y. View

Yang J, Sun Y, Xu F, Liu W, Hayashi T, Onodera S . Involvement of estrogen receptors in silibinin protection of pancreatic β-cells from TNFα- or IL-1β-induced cytotoxicity. Biomed Pharmacother. 2018; 102:344-353. DOI: 10.1016/j.biopha.2018.01.128. View

Mackenbach J, den Braver N, Beulens J . Spouses, social networks and other upstream determinants of type 2 diabetes mellitus. Diabetologia. 2018; 61(7):1517-1521. PMC: 6445479. DOI: 10.1007/s00125-018-4607-1. View

Rochette L, Zeller M, Cottin Y, Vergely C . Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta. 2014; 1840(9):2709-29. DOI: 10.1016/j.bbagen.2014.05.017. View

Tahrani A, Barnett A, Bailey C . Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nat Rev Endocrinol. 2016; 12(10):566-92. DOI: 10.1038/nrendo.2016.86. View

Shulman G . Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014; 371(12):1131-41. DOI: 10.1056/NEJMra1011035. View

Wang Q, Liu M, Liu W, Hao W, Tashiro S, Onodera S . In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of Sirt-1 expression and autophagy in pancreatic β-cell. J Asian Nat Prod Res. 2012; 14(5):413-23. DOI: 10.1080/10286020.2012.657180. View

Tiano J, Mauvais-Jarvis F . Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol. 2012; 8(6):342-51. DOI: 10.1038/nrendo.2011.242. View

Zheng N, Zhang P, Huang H, Liu W, Hayashi T, Zang L . ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells. J Pharmacol Sci. 2015; 128(3):97-107. DOI: 10.1016/j.jphs.2015.05.001. View

10.

Pi J, Zhang Q, Fu J, Woods C, Hou Y, Corkey B . ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol. 2009; 244(1):77-83. PMC: 2837798. DOI: 10.1016/j.taap.2009.05.025. View

11.

Hung H, Qian K, Morris-Natschke S, Hsu C, Lee K . Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep. 2012; 29(5):580-606. DOI: 10.1039/c2np00074a. View

12.

Wu J, Williams D, Walter G, Thompson W, Sidell N . Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells. Exp Cell Res. 2014; 328(2):351-60. DOI: 10.1016/j.yexcr.2014.08.030. View

13.

Zhang T, Liang X, Shi L, Wang L, Chen J, Kang C . Estrogen receptor and PI3K/Akt signaling pathway involvement in S-(-)equol-induced activation of Nrf2/ARE in endothelial cells. PLoS One. 2013; 8(11):e79075. PMC: 3833998. DOI: 10.1371/journal.pone.0079075. View

14.

Chen K, Zhao L, He H, Wan X, Wang F, Mo Z . Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway. Int J Mol Med. 2014; 34(4):1073-80. DOI: 10.3892/ijmm.2014.1883. View

15.

Lee S, Choi S, Jung I, Lee K, Kang Y . Protective effect of nicotinamide on high glucose/palmitate-induced glucolipotoxicity to INS-1 beta cells is attributed to its inhibitory activity to sirtuins. Arch Biochem Biophys. 2013; 535(2):187-96. DOI: 10.1016/j.abb.2013.03.011. View

16.

Gerber P, Rutter G . The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. Antioxid Redox Signal. 2016; 26(10):501-518. PMC: 5372767. DOI: 10.1089/ars.2016.6755. View

17.

Sone H, Kagawa Y . Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia. 2004; 48(1):58-67. DOI: 10.1007/s00125-004-1605-2. View

18.

Chu C, Li D, Zhang S, Ikejima T, Jia Y, Wang D . Role of silibinin in the management of diabetes mellitus and its complications. Arch Pharm Res. 2018; 41(8):785-796. DOI: 10.1007/s12272-018-1047-x. View

19.

Giannarelli R, Aragona M, Coppelli A, Del Prato S . Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 2003; 29(4 Pt 2):6S28-35. DOI: 10.1016/s1262-3636(03)72785-2. View

20.

Xu F, Yang J, Negishi H, Sun Y, Li D, Zhang X . Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats. Food Funct. 2018; 9(9):4926-4935. DOI: 10.1039/c8fo00565f. View